Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

NCT01049919 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

153

Enrollment

INDUSTRY

Sponsor class

Stopped Primary endpoint not met, remaining long-term follow-up not needed.

Conditions

Critical Limb Ischemia
Peripheral Arterial Disease
Peripheral Vascular Disease

Interventions

DEVICE: Bone marrow concentration device
PROCEDURE: Placebo procedure (sham)

Sponsor

Zimmer Biomet